This is a list of Phase 3 trials with primary completion dates in January 2024 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool.
and clinical practice issues, the phase 3 trial firmatory phase 3 m IrASO l trial are expected in early 2024. This drug is an antibody drug conjugate (ADC); these agents are already being
3 pivotal trial and begin Phase 3 in the first quarter of 2024. Type Phase 1 clinical trial for VX-407 in 2024. While Vertex
meloxicam. Intravenous Tramadol in Phase 3 Clinical Trials In its first phase 3 clinical trial, intravenous (IV) tramadol has met its
New Drugs and Clinical Trials Rules, 2024 ; 6, 20_S.O. 553(E)_ Stockpiling of new drug under phase 3 of clinical trial_NDCTR 2024, Feb-09 ; 7
This is a list of Phase 3 trials with primary completion dates in July 2024 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool.
This phase III trial compares the addition of an immunotherapy drug This is a Phase 3, open-label, randomized, clinical trial evaluating
Single-arm trial with 3 phases: dose confirmation phase (n=6 for 3 National Reimbursement Drug List. NRG. National Clinical Trials
Approximately 70% of drugs are successful in this phase and move to Phase 2 clinical trials. Phase 2 and 3 trials 2024/8/Bioanalysis-in-drug-
Comments